ASX Announcements
Market Sensitive
December 2024 Quarterly Activities Report and Appendix 4C
CTE – Second Quarter Cashflow Report, CTE - Second Quarter Activity Report
- Jan 31, 2025
- 10 pages
Change of Director's Interest Notice - V. Ippolito
Change of Director’s Interest Notice
- Jan 17, 2025
- 3 pages
Change of Director's Interest Notice - V. Ippolito
Change of Director’s Interest Notice
- Jan 9, 2025
- 2 pages
Application for quotation of securities - BOT
Appendix 2A (Application for Quotation of Securities)
- Jan 9, 2025
- 6 pages
January
This media company’s share price is tipped to double
Lennox small caps manager Liam Donohue says he’s bullish on Botanix Pharmaceuticals and explains why he is eyeing up some former market darlings.
- Joanne Tran
September 2024
The five pharma stocks exciting investors
Risky but with rewards, Australian pharmaceutical companies developing treatments for rare diseases are competing for investor attention.
- Michael Smith
August 2022
Botanix Pharmaceuticals raising for its sweating treatment
Botanix Pharmaceuticals, a listed developer of treatments for skin infections and diseases, was pitching investors for $5 million to take its Sofpironium Bromide product into sales in the United States.
- Anthony Macdonald, Sarah Thompson and Kanika Sood